Market Research Logo

China Pharmaceuticals & Healthcare Q3 2019

China Pharmaceuticals & Healthcare Q3 2019

Key View:

China remains one of the most attractive APAC markets for innovative drugmakers. In the coming years, the Chinesepharmaceutical market will grow modestly with medicine sales driven an ageing population and high disease burden. Newregulatory pathways and improvements to China’s drug approval process will bolster long-term growth opportunities fordrugmakers. Although this is favourable to innovative drugmakers, patented drug sales will be limited by the government’s drugpricing and reimbursement policies as well as other cost-containment measures.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
13th Five-Year Plan: Key Points
Market Overview
Competitive Landscape
Company Profile
AstraZeneca
Bayer HealthCare
China Shijiazhuang Pharmaceutical Group (CSPC)
Eli Lilly (Lilly China)
GlaxoSmithKline
MSD
Merck KGaA
North China Pharmaceutical Corporation
Novartis
Pfizer
Roche
Sanofi
Shanghai Pharmaceuticals Holding Co
Sinopharm
China Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report